Quick Answer
NRC HEALTH reported Cash and Equivalents of $4.14 million for fiscal year 2025.
NRC HEALTH Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.14M | -2.2% |
| 2024 | $4.23M | -36.4% |
| 2023 | $6.65M | -73.4% |
| 2022 | $25.03M | -54.0% |
| 2021 | $54.36M | +56.7% |
| 2020 | $34.69M | +156.6% |
| 2019 | $13.52M | +4.0% |
| 2018 | $12.99M | -62.6% |
| 2017 | $34.73M | +5.2% |
| 2016 | $33.02M | -21.6% |
| 2015 | $42.15M | +5.3% |
| 2014 | $40.04M | +81.3% |
| 2013 | $22.09M | +166.6% |
| 2012 | $8.29M | +2.5% |
| 2011 | $8.08M | +129.7% |
| 2010 | $3.52M | +40.1% |
| 2009 | $2.51M | +126.5% |
| 2008 | $1.11M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.22M | -35.9% | -57.9% |
| June 30, 2025 | $5.27M | +987.4% | +110.8% |
| March 31, 2025 | $2.50M | +47.3% | -40.9% |
| December 31, 2024 | $4.23M | -36.4% | +22.3% |
| September 30, 2024 | $3.46M | -9.6% | +613.6% |
| June 30, 2024 | $485.0K | -97.8% | -71.5% |
| March 31, 2024 | $1.70M | -92.8% | -74.5% |
| December 31, 2023 | $6.65M | -73.4% | +73.8% |
- NRC HEALTH showed a decrease of -2.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, NRC HEALTH’s cash and equivalents has grown by 273.2% (from $1.11 million to $4.14 million).
- The most recent figure is from NRC HEALTH’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: